BELLUS Health (BLU)
BLU
Chronic Cough
BiotechSign Signal Grade
F
Signal Grade
15.6/100 composite signal score
Composite of clinical trial activity, dilution exposure, publications, short interest, and insider transactions — all from verified public filings.
Insider Buying
0
Clinical Activity
25
Pipeline Overview
- Therapeutic Focus
- Chronic Coughsrc
Clinical Trial Activity
1
Clinical Trial
(ClinicalTrials.gov aggregate)
(ClinicalTrials.gov aggregate)
1 Phase 3
Trial Phase Breakdown
0
PubMed Publications
0
Catalyst Records
ClinicalTrials.gov aggregate as of 2026-10-13. ClinicalTrials.gov
Get real-time catalyst alerts, analyst signals, dilution risk tracking, and full pipeline data for BELLUS Health.
Full BLU Dashboard Sign Up FreePrimary Sources
This page reports only records present in the BiotechSign source payload as of the generation date. It does not infer drug efficacy, clinical outcome probability, approval odds, revenue, market size, or unreported regulatory events.